Why a diabetes drug fell short of anticancer hopes
Favicon 
yubnub.news

Why a diabetes drug fell short of anticancer hopes

But the latest research has convinced Pollak and some others that treatment of cancers should be taken off the list. More studies, but no proof One of the first hints linking metformin to anticancer effects…